Let our work speak for itself.

Adnexi identified and engaged patient advocacy groups and digital opinion leaders to drive trial awareness in a rare oncology indication.

Adnexi's proprietary platform accelerated clinical trial enrollment through targeted digital screening and site matching for an ultra rare disease program.

The Adnexi platform powered a patient lead generation program to accelerate trial enrollment for a Phase 2 study in neurodegenerative disease.

Adnexi mapped the digital opinion leader landscape and influence networks for a digital therapeutic product launch strategy.

Adnexi's platform identified and profiled the most influential digital opinion leaders shaping the osteoporosis treatment landscape.